IPCA Laboratories - Q4FY'20 result - Angel Broking

Mr. Jyoti Roy, DVP Equity Strategist, Angel Broking Ltd.

"IPCA Laboratories Ltd. reported a 22% YoY growth in consolidated revenue to Rs. 1,074 crore for Q4FY20, driven by domestic formulations (+21% YoY) and generic exports (+40% YoY). EBITDA margins for the quarter increased to 21.47% as against 20.09% in Q4FY19.

The company has made a one time provision for impairment of intangibles assets of Rs. 27.64 crore during the quarter which had an adverse impact of profits. As a result consolidated net profit for the quarter was down to Rs. 83.1 crore as against Rs. 96.0 crore in Q4FY19. For FY20 the company reported strong profit growth of 36% YoY at Rs. 603.6 crores."

Shares of IPCA LABORATORIES LTD. was last trading in BSE at Rs.1593.7 as compared to the previous close of Rs. 1598.4. The total number of shares traded during the day was 44373 in over 4634 trades.

The stock hit an intraday high of Rs. 1623.95 and intraday low of 1510. The net turnover during the day was Rs. 70073919.

Source : Equity Bulls

Keywords